CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Standard TreatmentWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug1165 Ibuprofen Wiki 1.00
drug1701 Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions Wiki 1.00

Correlated MeSH Terms (4)

Name (Synonyms) Correlation
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Application of Colchicine Plus Herbal Phenolic Monoterpene Fractions to Treat COVID-19

In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with oral administration of Colchicine Plus Herbal phenolic monoterpene Fractions. Improvement in clinical, laboratory and radiological manifestations will be evaluated in treated patient compared to control group.

NCT04392141 COVID-19 Drug: Standard Treatment Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions

Primary Outcomes

Description: All cause of death

Measure: Mortality rate

Time: up to 30 days

Secondary Outcomes

Description: Mild, Moderate or Severe

Measure: Change in patients clinical manifestation

Time: up to 30 days

Description: days

Measure: Length of hospitalization

Time: up to 30 days

Measure: C-reactive protein

Time: up to 30 days

Measure: lymphocyte count

Time: up to 30 days

Measure: serum lactate dehydrogenase

Time: up to 30 days

Measure: serum Interleukin-6

Time: up to 30 days

Measure: erythrocyte sedimentation rate

Time: up to 30 days

No related HPO nodes (Using clinical trials)